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Escherichia coli O157:H7 is a commensal organism in cattle, but it is a pathogen in humans. This differential
expression of virulence suggests that specific virulence factors are regulated differently in human and bovine
hosts. To test this hypothesis, relative real-time reverse transcription-PCR was used to relate the expression
of several putative virulence genes (eae, espA, stx2, rfbE, ehxA, and iha) to that of the “housekeeping” gene gnd
during natural human and experimental bovine infection with E. coli O157:H7. We examined these genes in
fecal samples from eight humans and four calves. iha and espA were significantly more expressed in bovine
infections. rfbE and ehxA appeared to be more highly expressed in human infections, though these differences
did not achieve statistical significance. Our results support the hypothesis that some virulence-associated
genes of O157:H7 are differentially expressed in a host-specific manner.
Escherichia coli O157:H7, a human pathogen that causes
diarrhea, bloody diarrhea, and the hemolytic uremic syndrome
(HUS), has acquired multiple virulence factors that might aid
its pathogenicity. Principal among these are the phage-en-
coded Shiga toxins (Stx proteins), which inhibit protein syn-
thesis in eukaryotic cells (41), and the LEE pathogenicity is-
land, which encodes products associated with formation of
attaching-and-effacing lesions at the host surface (reviewed in
reference 13). E. coli O157:H7 also has a 92-kb nonconjugative
plasmid that encodes several putative virulence factors, includ-
ing enterohemolysin (encoded by ehxA, also termed hlyA [1,
5]), a member of the RTX family of exoproteins. E. coli
O157:H7 also expresses the IrgA homologue adhesin (Iha),
which was recently identified as a virulence factor in uropatho-
genic E. coli (16, 38).
Some of these factors can affect animal hosts. For example,
E. coli O157:H7 causes attaching-and-effacing lesions on cul-
tured bovine cells (31) and in neonatal calves (8). Despite this,
E. coli O157:H7 is not known to cause natural disease in any
host except humans. This discrepancy suggests the hypothesis
that specific virulence factors of E. coli O157:H7 are regulated
differently when the bacteria are in the human rather than the
bovine gut. To test this hypothesis, real-time reverse transcrip-
tion-PCR (RT-PCR) was employed to examine gene expres-
sion in fecal samples from children infected with E. coli
O157:H7 and from experimentally infected calves. The result-
ing data support the hypothesis that virulence genes are dif-
ferentially expressed in the human and bovine hosts.
MATERIALS AND METHODS
Strains and media. Bacteria were grown in a shaking incubator at 37°C in
Luria-Bertani (LB) medium. When appropriate, ampicillin (100 g/ml) or nali-
dixic acid (32 g/ml) was added. Strain 86-24 is a well-studied clinical isolate
of E. coli O157:H7 (39). Strain 86-24nalR (3) was used to infect calves.
ORN172(pIHA) contains iha on a high copy plasmid (38). Shiga toxin-producing
E. coli (STEC) O103:H2 expresses enterohemolysin at high levels (34).
Clinical samples. Fecal specimens from children infected with E. coli O157:H7
were obtained from the Pacific Northwest. The Institutional Review Boards of
the Children’s Hospital and Regional Medical Center, Seattle, Wash., approved
the use of these specimens, which were frozen immediately after collection and
stored at 70°C until use.
Six conventional Holstein calves were housed in isolation units and pre-
screened for health status and freedom from fecal STEC/enterohemorrhagic E.
coli. Half of the calves were obtained at 1 day of age, screened during week 1,
inoculated on day 8, monitored for fecal shedding for 7 days, and euthanized and
necropsied at 14 to 16 days of age. The remaining calves were obtained at 6
weeks of age, screened for 1 week, challenged at 7 weeks of age, monitored for
fecal shedding for 7 days, and euthanatized and necropsied between 54 and 58
days of age. Calves were orally challenged with 109 to 1010 CFU of E. coli
O157:H7 strain 86-24nalR and monitored for 6 to 8 days for appetite, demeanor,
diarrhea, and Nalr fecal E. coli O157:H7. At necropsy, approximately 50 g of
fecal sample from the rectum was mixed in a stomacher bag, aliquoted, and
frozen. The Washington State University Institutional Animal Care and Use
Committee approved this research.
Positive controls. To create stool with known amounts of E. coli O157:H7,
bacteria were grown in LB broth to an optical density at 600 nm of 0.6 and 108
CFU were added per gram of stool donated by a healthy volunteer. To examine
the sensitivity of the assay, stool was spiked with broth-grown E. coli O157:H7
diluted in phosphate-buffered saline.
RNA extraction from stool. RNA was extracted using a modification of the
silica-binding method (2, 4). Buffers L6, L11, L10, and L2 and silica were
prepared as described previously (2, 4). Guanidine isothiocyanate (GITC)-con-
taining buffers were stored in the dark and used within 3 weeks after preparation.
The silica pH was adjusted to exactly 2.0 using 32% HCl. Approximately 0.2 g
stool was mixed with 5 ml L6 containing 0.2 g polyvinylpyrrolidone (PVP-40). For
watery human samples and all bovine samples, the amount of stool was increased
to 0.4 g. The mixture was vortexed thoroughly and centrifuged for 5 min at 4,300
 g and 4°C. The supernatant was transferred to fresh tubes containing 2.5 ml
GITC-phenol (7.5 M GITC, 0.5% sodium dodecyl sulfate, 1 mM EDTA, 50 mM
sodium acetate [NaOAc] [pH 4.0], 50% H2O-saturated phenol) and 2.5 ml
chloroform. The solution was vortexed and centrifuged (5 min, 4,300  g, 4°C).
The aqueous phase was transferred to a fresh tube containing 10 ml ethanol
(EtOH) and 400 l 3 M NaOAc, incubated for 30 min at20°C, and centrifuged
(20 min, 4,300  g, 4°C). The precipitated nucleic acids were vacuum dried,
resuspended in 3 ml L11, and split into 1-ml aliquots in microcentrifuge tubes,
each containing 300 l silica (pH 2.0) to bind DNA. The tubes were vortexed
thoroughly, shaken (10 min, 4°C), and centrifuged (2 min, 2,000  g), and the
* Corresponding author. Mailing address: Department of Microbi-
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RNA-containing supernatants were transferred to a tube containing 700 l L10
and 200 l silica (pH 2.0) to bind RNA. Again, the tubes were vortexed thor-
oughly, shaken, and centrifuged under the same conditions, and the supernatants
were discarded. The RNA-containing pellets were washed twice with 1 ml L2,
twice with 1 ml 70% EtOH, and once with 1 ml acetone. The pellets were dried
by incubating the tubes with open lids at 56°C for 5 min. To elute RNA, 200 l
H2O was added to the tubes, which were then vortexed thoroughly and incubated
(56°C for 10 min with lids closed). RNA was concentrated by adding 3 volumes
EtOH, 1 volume 3 M NaOAc, and 1 l glycogen (Roche), freezing at 80°C
overnight, and centrifuging (20 min, 11,000  g, 4°C). Pelleted RNA was washed
with 70% EtOH, dried, and resuspended in a 1:1 solution of formamide and
H2O.
DNA was eliminated using Ambion’s (Austin, TX) “DNA-free” DNase. Sam-
ples were treated twice following the recommendations of the manufacturer,
using 1 unit of DNase per microgram of nucleic acid. RNA integrity after the
DNase treatment was confirmed by visualizing rRNA after electrophoretic sep-
aration in a 0.8% agarose gel.
Primers and probes. Primers and probes were designed using Primer Express
1.5 (PE Applied Biosystems) and modified to allow approximately 10 bp between
primer and probe binding sites. When possible, we used previously published
primers and probes (Table 1). TaqMan probes were ordered from Applied
Biosystems (Foster City, CA) and fluorescently labeled with 6-carboxyfluorescein
at the 5 end and minor groove binder/nonfluorescent quencher at the 3 end.
Primers and probes were tested using positive control (spiked) stools (described
above). Real time RT-PCR was also performed on normal stool without added
O157:H7 to confirm that amplification did not occur in the absence of E. coli
O157:H7. To determine the sensitivity of mRNA detection, real-time RT-PCR
was performed for each gene on stool from a healthy individual spiked with
dilutions of broth-grown bacteria.
Real-time RT-PCR. Real-time RT-PCR was performed on 50 ng fecal RNA by
using the Invitrogen SuperScript III Platinum one-step quantitative RT-PCR
system. TaqMan probes (described above) were used so that the reaction con-
tained two levels of specificity: (i) the annealing of specific primers and (ii)
hybridization of the probe. For each gene, amounts of primer, probe, and MgSO4
were optimized. These were used at the concentrations detailed in Table 2. All
reactions using clinical samples were performed in triplicate using RNA from a
single extraction. Reactions were run on a Rotor-Gene 2000 real-time cycler:
program parameters were 55°C for 25 min, 95°C for 2 min, and 45 cycles of 95°C
for 15 s and 60°C for 30 s. To confirm that RNA was free of DNA, an additional
reaction was included that was identical to the RT-PCR but substituted platinum
Taq for the RT enzyme mix provided in the kit. If a clinical specimen yielded no
amplicon for a particular gene, the reaction was repeated. If only two of the three
reactions yielded a product, these two were included in the analysis.
Standard curves. RNA was extracted from bacteria grown with shaking at
37°C to logarithmic phase (12). For each gene, real-time RT-PCR was performed
on 10, 5, 1, 0.5, and 0.1 ng of RNA. Conditions were identical to those used for
the clinical samples. A standard curve was generated by plotting log 10 ng RNA
on the x axis and the cycle threshold (CT) value on the y axis. The equation of the
slope of the best-fit line was used to determine relative amounts for each gene for
the clinical samples.
Determination of ratios of genes of interest to control gene. For each clinical
sample, real time RT-PCR was performed for each gene in triplicate in a single
experiment. The relative amounts of RNA were determined from the CT values
by reference to the standard curves. The average relative amount of the tran-
script of interest was then divided by the average relative amount of gnd to
determine the ratio for each gene.
TABLE 1. Primers and probes used in this study





eaeL.2004RT (forward) GTCTCAAACGCAAGCAACCA 59 eae 101 This work
eae-probe.2004RT (probe) TCGTGCGACGATAAC 69.4 This work
eaeR.2004RT (reverse) CATCACTGACTGTCGCACTAACAGT 59 This work
espAL-RT (forward) GCCAAACTTCCTCAAGACGTG 58.4 espA 100 This work
espA-probe (probe) CATAAGTGTAACTGGTATTC 67.7 This work
espAR-RT (reverse) CACCAGCGCTTAAATCACCAC 59.2 This work
gnd-L-TT (forward) GGTAATACCTTCTTCCAGGACACC 58 gnd 105 This work
gnd-probe (probe) CCGTGAGCTTTCTG 68.9 This work
gnd-R-TAT (reverse) TAGTGCGCCCTCCTCACC 58.3 This work
ehxAL-RT (forward) GATATATTCCATGGCGCAGATG 58.1 ehxA 77 This work
ehxA-probe (probe) TCGAAGGTAATTATGGT 63.4 This work
ehxAR-RT (reverse) CCATCATCGCCGTATAGTCG 57.7 27
IhaL.2004RT (forward) GCATCTCACGGATGCACTTG 58.8 iha 91 This work
iha-probe.2004RT (probe) CCGCTATGAACATCATG 70.2 This work
ihaR.2004RT (reverse) CAGATATGCACGCGGACTGA 59.4 This work
rfbEL-RT (forward) CAAGTCCACAAGGAAAGTAAAGATG 57.2 rfbE 85 This work
rfbE-probe (probe) CACTTATTGGATGGTCT 65 This work
rfbER-RT (reverse) ATTCCTCTCTTTCCTCTGCGG 58.5 44
stxIIL.June (forward) GATGTTTATGGCGGTTTTATTTGC 58.4 stx2 83 14
stxII-probe.June (probe) TCTGTTAATGCAATGGC 69.6 This work
stxIIR.June (reverse) TGGAAAACTCAATTTTACCTTTAGCA 59.6 14
a Probes were labeled with 6FAM at the 5 end and minor groove binder/nonfluorescent quencher at the 3 end.
b The melting temperature (Tm) was calculated in Primer Express.
TABLE 2. Optimized conditions for amplification of each gene
Gene Probe (nM) Primer (nM) MgSO4 (mM) Detectiona
eae 300 600 5 106
espA 300 400 5 106
ehxA 300 200 5 106
gnd 300 500 5 105
iha 300 400 5 105
rfbE 400 400 6 105
stx2 300 300 6 10
5
a CFU E. coli O157:H7/g of positive control stool containing smallest amount
of E. coli O157:H7 detectable by this primer set.
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Statistical analysis. For each putative virulence gene, the ratio of mRNA to
gnd mRNA for human samples was compared to that for bovine samples by using
the two-tailed Mann-Whitney test. Significance was set at 5%.
RESULTS
Selection of genes for study. To determine if virulence genes
are expressed differently when E. coli O157:H7 is excreted
from humans compared to cattle, we selected several known or
candidate virulence loci for expression analysis. These included
LEE pathogenicity island genes eae and espA, as well as the
gene encoding Shiga toxin 2 (stx2). stx2 was selected because,
unlike stx1 and other Shiga toxin variant genes, it is present in
nearly all North American isolates (26, 39). We also included
genes for which a role in human infection is uncertain: rfbE,
which is involved in the synthesis of the O antigen of lipopoly-
saccharide (LPS), and ehxA, which encodes enterohemolysin.
Finally, we included iha, which encodes Iha, an adherence-
conferring molecule that is a virulence factor in uropathogenic
E. coli (16, 38). Levels of expression of these genes were re-
lated to that of a constitutively expressed housekeeping gene,
gnd. gnd was selected as a reference locus because it is unusu-
ally polymorphic among E. coli housekeeping genes (25), en-
abling the specific analysis of expression of the O157:H7 gene
against a background of commensal E. coli. Moreover, it differs
from the gnd genes of related E. coli O55:H7 and E. coli with
the O157 rfb region, which are only distantly related to E. coli
O157:H7 and are not pathogens. Thus, gndO157:H7 provides a
target that is theoretically quite specific for the identification of
pathogenic E. coli O157:H7.
RNA extraction from fecal samples. We developed an ex-
traction method to isolate sufficiently pure RNA, free of
RNases and inhibitors of enzymatic reactions. First, we em-
ployed a silica-binding method (2, 4) to isolate intact RNA as
determined by separation on a 0.8% agarose gel (data not
shown). However, we were unable to amplify fecal RNA ob-
tained by this method, and we could not amplify RNA from
broth-grown bacteria mixed 1:1 with fecal RNA extracted us-
ing this method. We suspected that inhibition of amplification
reactions was at least in part the result of polyphenolics, which
inhibit PCR (19). Polyphenolics are found in the leaves, bark,
and fruit of most plants and reportedly copurify with nucleic
acids during extraction from plant material and sludge (23, 37).
PVP binds polyphenolics, and adding PVP-40 reduces inhibi-
tion of amplification by polyphenolics when included in an
RNA extraction (15, 36, 37). Therefore, additional steps to
optimize the RNA extraction protocol included adding PVP-40
in the lysis buffer, and the resulting procedure (see Materials
and Methods) enabled the isolation of RNA suitable for RT-
PCR from control (uninfected) human stool samples to which
O157:H7 was added (data not shown).
Selection and optimization of primers and probes. Primers
and TaqMan probes designed for real-time RT-PCR are
shown in Table 1. Optimum concentrations of primer, probe,
and MgSO4 were determined (Table 2) using positive control
stools (described in Materials and Methods). For each gene, an
increase in fluorescence during real-time RT-PCR was ob-
served for RNA from human stool spiked with E. coli O157:H7
but not for RNA from unspiked stool containing commensal
E. coli (data not shown). Furthermore, gene expression was not
detected in RNA from a bovine fecal sample taken before
infection (data not shown), nor was it detected in bovine sam-
ples with low numbers of E. coli O157:H7 (see below). Thus,
the primers and probes are specific for E. coli O157:H7 and do
not amplify codefecated flora.
The sensitivity of the assay was determined by performing
real-time RT-PCR on control stool spiked with serial dilutions
of broth-grown E. coli O157:H7, ORN172(pIHA) (for iha), or
STEC O103:H2 (for ehxA). ORN172(pIHA) and STEC
O103:H2 highly express iha and ehxA, respectively, and were
used because LB-grown O157:H7 expressed these genes at
very low levels. The lowest dilution for which an increase in
fluorescence was observed for each gene is listed in Table 2.
Analysis of human and bovine specimens. RNA was ex-
tracted from eight human and four bovine specimens. Six bo-
vine specimens were available, but we could detect E. coli
O157:H7 gene expression in only four. The remaining two
specimens contained 104 CFU E. coli O157:H7/g. Each gene
was amplified from each RNA preparation in triplicate. For
the majority of the 80 reactions performed in triplicate, the
CT values within the triplicates varied by 10%. For four
reactions, the CT values of the triplicates varied by 35%.
These four were cases in which the CT value was30, i.e., near
the limit of detection. The relative amounts of RNA were
determined from the experimental CT values by reference to
the standard curves.
Average relative amounts of mRNA for each gene were then
normalized to the average relative amount of gnd mRNA of
the same specimen. The resulting ratios were compared be-
tween human and bovine specimens by using the two-tailed
Mann-Whitney test independently for each gene. For calf no.
3, in which expression of only some genes was detected, the
sample was excluded from analysis for the genes whose expres-
sion was not detected. We elected to exclude these samples
rather than assign an arbitrary low number because our statis-
tical analysis used a nonparametric method that requires that
the data be rank ordered. Assigning an artificial value had the
potential to denote that data point with an incorrect rank and
might have invalidated the results. Table 3 indicates the ratios
of expression relative to gnd.
iha and espA exhibited statistically significant differences in
expression between human and bovine hosts (Fig. 1). In both
cases, the genes were more highly expressed in cattle feces. In
contrast, ehxA (Fig. 2) (P  0.073) and rfbE (P  0.11) ap-
peared to be more highly expressed in human stool, although
these results failed to achieve statistical significance.
DISCUSSION
In addition to providing insight into host-specific virulence
factor expression, we believe this study to be the first descrip-
tion of quantitative determination of specific bacterial mRNA
levels in feces containing commensal flora. Preparation of
RNA from cholera patient stools has previously been de-
scribed (20, 22); however, these analytes were described as
having a rice-water appearance characteristic of Vibrio cholerae
stool, and microscopically, they contained few nonvibrios.
Those authors did not mention any problems with inhibition
and were able to extract RNA by using Trizol reagent, a phe-
nol-chloroform based method. This suggests that cholera pa-
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tient stools are relatively pure cultures of V. cholerae that
possess few inhibitors. In contrast, our specimens were rarely
aqueous, contained abundant commensal E. coli and other
bacterial flora, and sometimes also contained blood or plant
material which can inhibit PCR. We therefore believe that our
RNA extraction technique can be applied to study gene ex-
pression of other bacteria that reside in the microbially com-
plex milieu of the vertebrate intestine.
Because our specimens contained variable numbers of E.
coli O157:H7, it was necessary to normalize virulence gene
expression to an O157-specific control gene. gnd encodes the
third enzyme of the pentose-phosphate pathway and is adja-
cent to the rfb cluster on the chromosome. Selective pressure
for O-antigen diversity has led to a high mobility rate for the
rfb region, and this recombination has also involved the neigh-
boring gene gnd, which cotransfers with rfb (25, 40), generating
variation in gnd. Therefore, though it is a housekeeping gene,
FIG. 1. Genes differentially expressed in human and bovine hosts.
iha (A) or espA (B) expression normalized to gnd expression is shown
with specimens grouped by source. The bars represent the means for
human and bovine specimens (P  0.05).
FIG. 2. ehxA exhibits a trend towards differential expression. ehxA
expression normalized to gnd expression is shown with specimens
grouped by source. The bars represent the means for human and
bovine specimens (P  0.073).
TABLE 3. Ratios of gene expression to that of gnda
Sample no. Typeb Patient outcomec Specimen statusd Specimenconsistency CFU O157:H7/g
Ratio of transcript to that of gnda
eae espA ehxA gnd iha rfbE stx2
1 Bovine Normal Normal Normal 4.9  106 18 19 0.6 1 0.09 0.048 15
2 Bovine Normal Normal Normal 9.4  105 3.5 5 0.41 1 0.57 0.024 1.3
7 Bovine Normal Normal Normal 1.5  104 36 11 0.27 1 1.8 0.026 0.97
3 Bovine Normal Normal Normal 2.5  107 0.01 1 0.04 0.0001 0.05
A Human Diarrhea Uncomplicated Watery 2 109 15 1.8 2 1 0.04 0.11 0.63
B Human Diarrhea Uncomplicated Solid 1.2 108 13 15 3.6 1 0.03 0.11 0.55
C Human Bloody diarrhea, HUS Pre-HUS Watery 1.1 108 12 3.3 5.1 1 0.05 0.28 9.1
D Human Bloody diarrhea Uncomplicated Solid 1 108 0.3 0.13 0.46 1 0.03 0.02 0.48
E Human Bloody diarrhea Uncomplicated Solid 1 108 0.7 0.28 0.09 1 0.01 0.0032 0.47
F Human Diarrhea Uncomplicated Soft 6 107 3.6 0.93 4.2 1 0.02 0.23 1.4
G Human Bloody diarrhea, HUS HUS Watery 3 107 3 1 0.56 1 0.02 0.066 0.29
H Human Bloody diarrhea Uncomplicated Watery 1.8 107 5.3 1.6 3.4 1 0.03 0.38 1
a The relative amount of each transcript was determined using standard curves, following which transcripts of the genes of interest were normalized to gnd.
b All bovine samples were from calves obtained at 1 day of age except no. 7, which was obtained at 6 weeks of age.
c Refers to ultimate outcome.
d Refers to patient status at time sample was taken.
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gnd is sufficiently polymorphic that we could design primers
and probes specific for gnd of E. coli O157:H7. gnd mRNA
abundance is regulated by the growth rate and fluctuates by
2.5-fold when grown on acetate versus glucose (29). This reg-
ulation is the result of growth rate rather than carbon source
(45), and further regulation of 6-phophogluconate dehydroge-
nase levels is achieved by posttranscriptional regulation via
blocking of translation initiation (6). rRNA is often used as a
constitutively expressed control, and its synthesis is also regu-
lated according to growth rate (reviewed in reference 28).
Therefore, gnd provides a comparable, O157-specific control
for our specimens. It might also be a useful target for identi-
fying E. coli O157:H7 in other microbially complex substances
such as food or environmental samples.
In our samples, gnd expression roughly correlated with
CFU/g of E. coli O157:H7, especially for the bovine samples
(see supplementary Table 1 at http://faculty.washington.edu
/moseley/rashidsup.pdf). For human fecal samples with a solid
consistency we detected lower abundances of all genes, includ-
ing gnd, than in human fecal samples with a liquid consistency.
We speculate that this is the result of additional inhibitors from
food being present in solid fecal samples, thus reducing detec-
tion of all messages. In support of this, samples B and C both
contain approximately 108 CFU/g, but sample B is of solid
consistency and C is of watery consistency (Table 3; see sup-
plementary Table 1 at http://faculty.washington.edu/moseley
/rashidsup.pdf). Supplementary Table 1 shows the raw data for
all samples, and values for all genes are lower in the solid
sample B. This suggests that inhibitors present in this and
other solid samples affect all genes equally and further illus-
trates the need to normalize data internally prior to comparing
across samples. In human samples, we observed the highest
levels of gnd mRNA in the samples with the highest CFU per
gram, which were of a liquid consistency. We did not detect gnd
mRNA in fecal samples from a healthy human or a calf prior
to infection, nor were we able to detect gnd in specimens from
two calves with low CFU per gram. Thus, we conclude that
detection of the O157:H7 gnd allele message by our primers
specifies the presence of E. coli O157:H7.
We were able to detect gene expression in bovine and hu-
man clinical specimens at concentrations lower than those
found to be the limit of detection in positive control stool
(Table 2). We believe that this reflects a combination of dif-
ferences in the inhibitors present in these specimens and dif-
ferences in gene expression between broth-grown and feces-
grown bacteria.
We found iha and espA to be more highly expressed in cattle
than in humans. Iha, encoded by iha, is an adherence factor
found among several pathotypes of E. coli (38, 42). espA is
located in the LEE pathogenicity island, and EspA is impor-
tant in forming a filament that bridges the bacterium and host
cell and may be involved in protein translocation (17). Both
Iha and EspA might play a role during colonization of the
bovine intestine. In fact, EspA has been shown to be a colo-
nization factor of STEC O26:H during bovine colonization
(43), and the LEE pathogenicity island was demonstrated to be
important for bovine colonization of O157:H7 (10). Our data
suggest that Iha might also act as a colonization factor in cattle.
Host species specificity of colonization factors is well known.
For example, different virulence factors of Salmonella enterica
serovar Typhimurium are required for colonization of cattle
compared to chickens (24). Similarly, Iha may play a more
important role in bovine colonization than in human diarrheal
disease. Such a role may allow Iha-expressing STEC to persist
in their animal reservoirs prior to transmission to humans.
Another possible explanation for increased detection of iha
and espA in cattle could be the presence of non-O157:H7 E.
coli that contains these genes. However, in two specimens
containing few O157:H7 CFU per gram of stool, we were
unable to amplify any of the genes of interest, including iha and
espA, and in a third we were unable to amplify espA. Addition-
ally, we did not observe expression of any of these loci in a
fecal sample from calf no. 7 prior to infection with E. coli
O157:H7. This argues against the possibility that detection
of these genes was the result of non-O157:H7 E. coli. In-
creased expression of iha and espA in O157:H7 remains the
simplest and most likely explanation for detection of those
genes in the bovine specimens.
Additional genes analyzed demonstrated trends towards
higher expression in one species of host versus the other. We
expect that this may have reached statistical significance had
more specimens been available for analysis. Consistent with
higher expression of LEE pathogenicity island gene espA in
calves, eae also demonstrated a trend towards higher expres-
sion in calves. rfbE demonstrated a trend towards higher ex-
pression in the human, as did ehxA. rfbE, also called per, is
necessary for expression of the O157 antigen on LPS (3). It is
unclear why the bacterium would benefit from increased O-
antigen expression in the human host compared to the bovine
host. Perhaps the LPS provides a protective benefit to the
bacterium. Although enterohemolysin has been demonstrated
to have pore-forming activity (35), a defined role for this toxin
during pathogenesis has been unclear. Our data support the
possibility that enterohemolysin plays a role during human
pathogenesis by E. coli O157:H7.
Iha is repressed by iron (R. A. Rashid, P. I. Tarr, and S. L.
Moseley, submitted for publication). Our observation that iha
is more highly expressed in cattle could indicate that the bovine
host is more iron limiting than the human host. However,
enterohemolysin expression is increased when cells are grown
in iron-restricting medium (7), and ehxA showed a trend to-
wards higher expression in specimens of human origin. This
suggests that iron levels alone are unlikely to account for dif-
ferences in expression of these genes.
Interestingly, not all genes demonstrated a trend towards
host-specific expression: stx2 was not apparently differentially
expressed. This observation could be due to a slight difference
in expression that was undetected among the few specimens
analyzed. Alternatively, the possibility exists that stx2 is equally
expressed in humans and bovines. Indeed, stx2 is a late gene
product of the temperate bacteriophage 933W (32). It has
previously been noted that cattle may lack vascular Shiga toxin
receptors (33) and that some Shiga toxins are activated by a
compound present in mucus (18, 21). In conjunction with our
data, these studies suggest the possibility that Stx-mediated
pathogenesis may in part be regulated at the host level via
receptors, activation of toxin, and possibly other factors.
We excluded from analysis those samples for which we did
not detect expression, rather than assigning an arbitrary num-
ber. For calf no. 3, gnd levels were high. If espA is truly ex-
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pressed below the limit of detection, then it might be valid to
assign a low value for the espA ratio. If espA expression from
this animal is assigned the lowest rank, statistical significance
of the difference between espA expression in humans and cattle
is lost. However, we do not know that our inability to detect
espA in this sample is the result of low gene expression. Other
possibilities include the loss or mutation of the LEE pathoge-
nicity island during the course of infection or unexplained
technical problems with the assay of this specimen. For these
reasons, we elected to include in the analysis only samples for
which we were able to detect message.
We observed wide variation of expression for a given gene
within a host species. We do not believe this reflects detection
of gene expression of normal flora for reasons described above.
However, we are unable to explain the variation by correlating
increased gene expression with disease status of the donor. It
may be that fecal samples represent gene expression from a
variety of locations within the intestine, including both adher-
ent and nonadherent bacteria, which may have different gene
expression profiles. Variability of gene expression from sample
to sample remains a limitation of these data, and assessment of
biological significance must be approached with caution.
Another limitation of our data is that the transcriptome of E.
coli O157:H7 in feces may differ from that in organisms ad-
hering to the mucosal surface in the intestines. Several studies
have demonstrated in vitro the influence of epithelial adher-
ence on bacterial gene expression (11, 30). Analysis of expres-
sion levels of bacteria at this site during the course of human
infection would require biopsy material that would be diffi-
cult to obtain in sufficient quantity for analysis. Therefore,
examination of fecal bacteria seems a practical alternative.
In support of this method, Larocque et al. detected differ-
ential gene expression between early and late stages of in-
fection with V. cholerae by measuring gene expression in
vomitus and feces (20).
It has previously been observed that E. coli O157:H7 regu-
lates virulence gene expression in a lineage-specific manner
(9). Our data suggest that this organism additionally regulates
virulence gene expression in a host-specific manner.
In conclusion, our data support the hypothesis that at least a
subset of E. coli O157:H7 virulence gene expression alters
according to the host species. Additionally, our study provides
a method of bacterial RNA isolation from mixed-flora fecal
specimens that contain inhibitors, which may prove useful in
the study of other intestinal tract pathogens and of the human
enteric transcriptome in various additional states.
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